The effect of statin therapy on vessel wall properties in type 2 diabetes without manifest cardiovascular disease Beishuizen, E.D.

Peripheral blood cells were stained with HLA-A2.1 tetramers containing the tyrosinase368–376 peptide followed by staining with a panel of lineage antibodies, as described in

Blades and blade fragments seem to have been especially used for longitudinal motions, mainly on plant material (7/12). Flake and flake fragments are used in different motions on

The endpoints of this study were diff erences in infl ammatory markers (serum C-reactive protein (CRP) and fi brinogen levels), endothelial function (as estimated using measure-

In the patient group completing the study with full AECG data (n=155), there was a nonsignifi cant diff erence between the placebo and statin group with a higher prevalence

The present thesis describes a study, designed at a timepoint when no primary prevention trial had yet been performed to investigate the eff ects of statin therapy on patients with

In Hoofdstuk 3 wordt het belangrijkste eindpunt van het onderzoek beschreven, namelijk de eff ecten van 2 jaar statine op de IMT van de halsslagaders bij patiënten met DM2 zonder

The effect of statin therapy on vessel wall properties in type 2 diabetes without manifest cardiovascular disease..

In de richtlijnen voor primaire preventie van hart-en vaatziekten bij mensen met diabetes mellitus type 2 moet meer aandacht komen voor risico-stratificatie (dit proefschrift) 47.